Tomas L. Lindahl
Direttore/Membro del Consiglio presso MEDIROX AB
Profilo
Tomas L.
Lindahl founded Diapensia HB in 1992, where he is working as Chief Executive Officer from 1992.
Mr. Lindahl also currently works at Nordic Haemostasis AB, as Chairman and MediRox AB, as Independent Director from 2014.
Posizioni attive di Tomas L. Lindahl
| Società | Posizione | Inizio |
|---|---|---|
| MEDIROX AB | Direttore/Membro del Consiglio | 01/08/2014 |
| Diapensia HB | Amministratore Delegato | 01/01/1992 |
| Nordic Haemostasis AB | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden. | Health Technology |
| Diapensia HB | |
| Nordic Haemostasis AB |
- Borsa valori
- Insiders
- Tomas L. Lindahl
